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ABSTRACT 
Amyotrophic Lateral Sclerosis (ALS) is a progressively debilitating neuro-degenerative 
condition that occurs in adulthood and targets the motor neurons. Social support is crucial to the 
well-being and quality of life of people with unpredictable and incurable diseases such as ALS. 
Members of the PatientsLikeMe (PLM) ALS online support community share social support but 
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also exchange and build distributed knowledge within their discussion forum. This qualitative 
analysis of 1000 posts from the PLM ALS online discussion examines the social support within the 
PLM ALS online community, and explores ways community members share and build knowledge. 
The analysis responds to three research questions: RQ1: How and why is knowledge shared among 
the distributed participants in the PLM-ALS threaded discussion forum?; RQ2: How do the 
participants in the PLM ALS threaded discussion forum work together to discover knowledge about 
treatments and to keep knowledge discovered over time?; and RQ3: How do participants in the 
PLM-ALS forum co-create and treat authoritative knowledge from multiple sources including the 
medical literature, health care professionals, lived experiences of patients and "other" sources of 
information such as lay literature and alternative health providers? The findings have implications 
for supporting knowledge sharing and discovery in addition to social support for patients.   
INTRODUCTION 
Social support is crucial to patients’ well-being and overall quality of life. It plays an 
important role in reducing stress, increasing access to emotional and tangible support, and 
improving medication adherence and compliance with treatment plans (Cohen et al., 2007; 
Griffiths, Calear, Banfield, & Tam, 2009; Shigaki et al., 2008; Wright & Bell, 2003). Widespread 
access to social support is facilitated by a growing number of web-based platforms such as social 
networking sites (e.g., Facebook) and blogs in addition to more traditional approaches like 
discussion forums and listservs. The ability to participate in supportive communications is 
particularly valuable for individuals suffering from chronic diseases that may not be widely 
understood or for which a cure is not yet available (Coulson, Buchanan, & Aubeeluck, 2007; 
Davison, Pennebaker, & Dickerson, 2000; Lasker, Sogolow, & Sharim, 2005; Mo & Coulson, 
2008). As the patient’s disease progresses, these opportunities for peer-to-peer knowledge sharing 
and building are just as important for their caregivers who become increasingly involved in their 
patient’s care and their day-to-day living. 
To date, the corpus of research on online social support groups has focused on examining 
the effects of online social support on the psychosocial functioning and well-being of patients as 
well as on the types of information exchanged within these networks. In contrast, the current study 
examines participation in online supportive communications from the perspective of knowledge 
sharing and creation. Patients and their caregivers play critical roles in building the knowledge base 
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about day-to-day and caregiving experiences that might not be adequately discussed or discovered 
in clinical encounters. 
The study specifically examines a socially supportive online community of individuals 
touched by Amyotrophic lateral sclerosis (ALS), including patients, their caregivers, and clinicians. 
Also known as Lou Gehrig’s disease, ALS is a progressively debilitating neuro-degenerative 
condition that occurs in adulthood and targets the motor neurons. This article explores the ways that 
members of this community, who are distributed across space and through time, share and build 
knowledge about this rare and fatal disease whose causes and treatments are largely unknown. 
Unlike traditional online social support systems, PLM provides formalized mechanisms for 
members to find other patients like themselves and share their medical data and information about 
their treatments. In addition, it has the ability to aggregate and visualize this data, which in turn 
becomes a valuable tool for evaluating the effects of various medications and treatments on patient-
reported outcomes (Wicks et al., 2010; Wicks, Vaughan, Massagli, & Heywood, 2011). This unique 
collaborative sharing environment makes it particularly appropriate for exploring PLM as a locus 
for knowledge building. 
This study examines knowledge-building processes in the PLM-ALS community through 
the lens of two concepts closely tied to distributed knowledge: undiscovered public knowledge and 
authoritative knowledge. The discovery of public knowledge is important in communities like PLM-
ALS where related information about causes, treatments, symptoms, and co-occurring conditions is 
not always stored together or clearly linked. It explores the key roles patients and their caregivers 
play in filtering information, creating knowledge and discovering existing-but-hidden knowledge as 
their disease progresses; sharing information from multiple sources, people, and systems; 
and helping one another manage the sometimes complex relationships of authority and expertise 
among patients, caregivers, health care professionals, and others who provide treatments to people 
with rare diseases like ALS.  And because these exchanges are based on patients’ lived experiences, 
it has become an important resource for understanding this rare disease with implications for the 
discovery of better treatments and potentially, a cure. 
To explore those aspects in the PLM-ALS community, this analysis posed the following 
research questions: 
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RQ1: How and why is knowledge shared among the distributed participants in the PLM-
ALS threaded discussion forum? 
RQ2: How do the participants in the PLM ALS threaded discussion forum work together to 
discover knowledge about treatments and to keep knowledge discovered over time? 
RQ3: How do participants in the PLM-ALS forum co-create and treat authoritative 
knowledge from multiple sources including the medical literature, health care professionals, lived 
experiences of patients and "other" sources of information such as lay literature and alternative 
health providers? 
Answering these questions will help us understand how to support knowledge sharing and 
discovery among distributed groups of patients – particularly, how to help make their knowledge 
public and maintain it over time. The findings may lead to a better understanding of “authoritative 
knowledge” and how patients’ experiences, knowledge, and opinions are important for the creation 
of a mutually-agreed upon treatment plan that in turn can improve compliance and enhance the 
therapeutic alliance between patients and their doctors. Finally, these findings will have 
implications for designing and for improving systems (such as PLM) in order to better facilitate 
knowledge sharing while minimizing the chances for misinformation. This in turn may facilitate the 
discovery of better treatments for this rare and debilitating disease and help improve patients’ 
quality of life. 
BACKGROUND 
PatientsLikeMe and ALS 
PatientsLikeMe (PLM; http://www.patientslikeme.com/) is an online community that uses 
various technologies including social media and user-generated content to facilitate the exchange of 
social support. The site couples the functionality of online discussions with tools to report and 
review patients’ medical histories (Wicks et al., 2010). Symptoms, treatments and outcomes are 
charted on individual profiles and aggregated into interactive reports. On PatientsLikeMe, patients 
can review and respond to changes in their own medical history, use the records of these changes 
when interacting with their physicians, find other people similar to themselves, and hold data-
centered discussions of health. The website offers free membership and supports more than 175,000 
 5 
(as of January 2013) patients with rare illnesses such as Amyotrophic Lateral Sclerosis, Multiple 
Sclerosis, and Parkinson’s Disease. 
The current study focuses on a qualitative analysis of the Amyotrophic Lateral Sclerosis 
(ALS) community within PLM. ALS is a rare and incurable disease affecting approximately 30,000 
Americans (Wijesekera & Leigh, 2009). This fatal, neurodegenerative disease attacks the nerves 
and muscles, resulting in the progressive loss of voluntary motor function which eventually leads to 
difficulties in speaking, swallowing, and breathing. While ALS contributes to the weakening of 
voluntary motor functioning and eventual paralysis, most patients can still think clearly and rely on 
various assistive technologies to aid in communication. The ability to communicate with others is 
an important aspect of patients’ ability to cope with their disease and remain active participants in 
their own care. 
As in the case of other rare, incurable diseases, ALS patients live with great uncertainty. In 
the majority of cases, onset occurs in the limbs where it causes spasms and loss of manual dexterity, 
muscular atrophy, weakness and finally, paralysis (Wijesekera & Leigh, 2009). In ALS, the 
paralysis progresses leading to respiratory failure and death within 2-3 years for bulbar onset cases 
and 3-5 years for limb onset cases (Wijesekera and Leigh, 2009). Riluzole is currently the sole 
FDA-approved drug for the treatment of ALS, but it only increases median survival by two to three 
months (Miller, Mitchell, & Moore, 2012) and costs $12,000 per patient (Messori, Trippoli, 
Becagli, & Zaccara, 1999). Clinical guidelines for the treatment of ALS lack empirical evidence and 
there is little ongoing research that might improve them. The guidelines that do exist rely on 
minimal evidence and small studies conducted with only 5 to 20 patients per trial arm (Miller et al., 
2009). Of the few trials conducted between 1998 and 2007, only one was a Class I randomized 
controlled trial rigorous enough to inform treatment recommendations.  
Without substantive research, clinical guidelines remain vague and many aspects of the 
condition remain understudied. As a result, there is great need for additional information on how to 
best care for people with ALS. Spurred by this challenge, brothers Benjamin and Jamie Heywood 
founded PatientsLikeMe in 2004 in response to the lack of treatment and care options for their 
brother, Stephen. Since then, PatientsLikeMe and its members have conducted studies about several 
aspects of ALS to fill gaps in medical research – e.g., patient preferences in the treatment of 
cognitive decline in ALS (Wicks & Frost, 2008), the prevalence of depression in ALS (Wicks et al., 
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2007), and the efficacy of an experimental treatment, Lithium, on clinical outcomes (Wicks, et al., 
2011). While these are not randomized controlled trials, these studies provide empirical evidence 
about otherwise understudied issues related to ALS. PLM members associate the routine use of the 
site with improved quality of life and care in several areas including: learning about symptoms, 
understanding the side-effects of treatment, and improved treatment outcomes for particular 
conditions (Wicks, et al., 2010). Knowledge sharing within online social support groups like PLM 
is crucial for helping improve the day-to-day quality of life of patients and, possibly, hasten 
improvements in the treatment of rare diseases like ALS. This is also particularly important in 
situations where healthcare providers and clinical experts do not have all the answers. The 
following section explores knowledge creation among members of this community through 
processes associated with the concept of distributed knowledge – specifically, the exchange of 
undiscovered public knowledge and authoritative knowledge related to ALS. 
Distributed Knowledge within the PLM/ALS Community 
Participants in the PLM-ALS discussion forum co-create knowledge about ALS and how to 
manage their disease trajectories by sharing information related to their diagnosis, symptom 
management, and drug and other treatments (Beaudoin & Tao, 2007; Berkman, 1995; Israel, 1985; 
Leimeister, Schweizer, Leimeister, & Kromar, 2008). As with other online communities, 
individuals participating in the PLM/ALS discussion board are not physically co-located and their 
interactions are asynchronous. The knowledge they build together is created through processes that 
are mainly made visible to us through the central hub of the online discussion. Less obvious in these 
forums are the contributions to knowledge building by other actors who do not directly contribute to 
the discussion (for example, the medical professionals who treat the ALS patients, their caregivers, 
the creators of literature they read, and others to whom they turn for advice, support, and 
information). Halpern and Moses (1990) describe such phenomena as distributed knowledge, 
"knowledge that is distributed among the members of the group, without any individual agent 
necessarily having it" (Halpern & Moses, 1990, p. 550). In other words, "a group has distributed 
knowledge of a fact ϕ if the knowledge of ϕ is distributed among its members, so that by pooling 
their knowledge together the members of the group can deduce ϕ, even though it may be the case 
that no member of the group individually knows ϕ" (Fagin, Halpern, Moses, & Vardi, 2003, p. 3).  
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Distributed knowledge processes occur when multiple actors are engaged in building, 
distributing, storing, using, or otherwise interacting with knowledge. Distributed knowledge 
processes can occur among multiple people and among different and disparate systems (computer 
systems, institutional systems, etc.) (Haythornthwaite, 2006). In such cases, physical distance 
(O'Leary & Cummings, 2007; Olson & Olson, 2000), cultural differences, and differences in 
practice (Haythornthwaite, 2006) affect these knowledge processes and what is built, discovered, re-
discovered or “lost” over time. From this perspective, temporal or chronological differences are also 
important, and vary from short term ones such as time-zone differences affecting collaborative 
knowledge work (Cummings, 2011) to long term ones in which what is known does not persist 
across time. A tragic yet apt example of knowledge becoming "unknown" over time is that of the 
volunteer who died at Johns Hopkins University in 2001 after inhaling hexamethonium as part of a 
research study, because even though: 
[T]he supervising physician, Dr. Alkis Togias, made "a good-faith effort" to research 
the drug's adverse effects, his search apparently focused on a limited number of 
resources, including PubMed, which is searchable only back to 1966. Previous 
articles published in the 1950s, however, with citations in subsequent publications, 
warned of lung damage associated with hexamethonium. (Perkins, 2001, n.p.) 
Distributed knowledge is thus not only distributed among members of a group or social 
world but is distributed across time and subject to decay as a result (Cramton, 2001). Knowledge 
can be distributed across multiple people within a social world but also across multiple social 
worlds, making it difficult to keep knowledge "known" (Haythornthwaite, 2006). Over time, the 
amount of useful knowledge held by individuals in distributed groups may decrease as they 
increasingly rely on information that is centrally stored (Griffith, Sawyer, & Neale, 2003).  
Distributed knowledge processes tend to occur particularly in health-related arenas. For 
example, medical knowledge is typically fragmented across different disciplines, specialties and 
systems making it difficult to recognize meaningful connections between disparate sources of 
evidence (undiscovered public knowledge). Moreover, that which patients may accept to be 
meaningful medical knowledge (authoritative knowledge) requires thoughtful consideration of 
information from multiple sources and individuals with different perceived levels of expertise.  
Undiscovered Public Knowledge  
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In framing the concept of undiscovered public knowledge (UPK) Swanson (1986, p. 103) 
wrote: "independently created pieces of knowledge can harbor an unseen, unknown, and unintended 
pattern." What is known and generally accepted—that is, public—in one place, group, discipline, or 
arena may have a relationship with knowledge from another arena, but these connections can 
remain undiscovered by people in either arena. Moreover, knowledge in one area may reinforce or 
refute what is known elsewhere or it may fill in a gap elsewhere. For example, those in one area 
(Arena A) may know they have a knowledge gap but do not know how to fill it, whilst those in 
another area (Arena B) may have a piece of knowledge that could fill a gap existing elsewhere 
(Swanson, 1986, p. 109). There may be a "missing link in the logic of discovery" (Swanson, 1986, 
p. 110) where a known relationship between A and B, held separately from a known relationship 
between B and C, makes it difficult to discover a relationship between A and C. Or, what may be 
hidden is the "cumulative strength of individually weak tests" (Swanson, 1986, p. 111), where what 
is known on the basis of relatively small studies or samples in disparate settings or disciplines could 
be combined to form a more persuasive aggregate finding. In all cases, the important factor is that 
the knowledge is simultaneously public, in the sense that it is accessible to people and to 
information systems, and also undiscovered, in the sense that the salient relationships or 
mechanisms that would render the knowledge usable remains hidden.  
The literature provides examples of salient characteristics of UPK in medical settings with 
most of this research focusing on information retrieval systems: developing systematic approaches 
to drug repurposing using various information retrieval techniques to extract UPK from the 
biomedical literature (Andronis, Sharma, Virvilis, Deftereos, & Persidis, 2011); building systems to 
support drug discovery by extracting, associating, and storing chemical terms from MEDLINE 
records (Baker & Hemminger, 2010); building systems to reveal UPK that lies hidden in the 
literature on bioterrorism (Dang et al., 2009); and using UPK to test a knowledge discovery system 
in MEDLINE (Koike & Takagi, 2007) and vice versa—using a knowledge discovery system in 
MEDLINE to test UPK (Gordon & Lindsay, 1996).  
Conversely, some research acknowledges the potential social aspects of discovering public 
knowledge where knowledge discovery also relies on interpersonal interactions and emotional 
negotiations. For example, social information foraging (Chi, Pirolli, & Lam, 2007; Pirolli, 2009) 
uses UPK as an informing concept to add "social dimensions to how people both use and create 
information in decentralized information systems" (Wohn, Lampe, Vitak, & Ellison, 2011, p. 1).  
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Authoritative Knowledge 
Authoritative knowledge is "that knowledge taken to be legitimate, consequential, official, 
worthy of discussion and useful for justifying actions by people engaged in accomplishing a given 
task" (Suchman & Jordan, 1997, p. 98). Jordan stresses, " By authoritative knowledge I mean…the 
knowledge that participants agree counts in a particular situation, that they see as consequential, on 
the basis of which they make decisions and provide justifications for courses of action. It is the 
knowledge that within a community is considered legitimate, consequential, official, worthy of 
discussion, and appropriate for justifying particular actions by people engaged in accomplishing the 
tasks at hand." (Jordan, 1997, p. 58) 
Authoritative knowledge is socially co-constructed by members of a community, and is not 
defined by hierarchies of power or authority. It is something to be built, rather than sought, and 
includes contributions of opinion, emotion, bodily experience, and social experience. Jordan writes 
that "By authoritative knowledge I specifically do not mean the knowledge of people in authority 
positions" (Jordan, 1997, p. 58). Authoritative knowledge is both situated in a community and is 
"assembled … from a shared history and from the experience of those present" and involves input 
from participants of varying "ranks" as seen from the outside (e.g., the patient, family, medical 
professionals, lay caregivers, and others) but who, within the specific situation, all contribute to a 
"shared store of knowledge" (Jordan, 1997, p. 60). 
Conflicts arising during the construction of authoritative knowledge can occur when 
patients' knowledge (i.e., their experience) contradicts that held by medical professionals, or when 
multiple experts consider contradictory "facts" to be "known" (Kingfisher & Millard, 1998). In both 
cases, conflict arises when multiple parties do not share an understanding of what knowledge is 
meaningful in their setting, regardless of the perceived “authority” of experts conferred on them by 
virtue of their role or educational attainment (Kingfisher & Millard, 1998).  
Processes governing the construction of authoritative knowledge are demonstrated not only 
when people are making decisions about medical treatments but also when they are making or 
justifying claims related to their knowledge about the efficacy of such treatments (Oliphant, 2009). 
For example, making decisions about treatments requires resolving conflicts among published and 
established knowledge in the medical literature, clinical experience of health care professionals, 
"other" sources of information (such as lay literature and alternative health providers) whose 
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authority may be questioned within the framework of established medical practice, and lived 
experiences of patients (McCoyd, 2010). Treatment decisions, which ideally should be mutually 
developed and agreed upon by patients and their doctors, may in reality reflect uneven power 
relationships, and their application (by the health professional) or uptake (by the patient) may not 
match the knowledge-based expectations of all those involved (see, e.g., Kingfisher & Millard, 
1998).  
PLM provides a platform where participants can socially construct their own authoritative 
knowledge, that is, the knowledge considered to be authoritative within that community based on 
their shared way of seeing the world. It exists apart from the enforced hierarchy of the clinical 
setting, a separation that allows the community freedom about what knowledge they can consider to 
be legitimate. But, as will be seen in the following data analysis, it does not exist in a vacuum, nor 
does it involve a complete rejection of publicly accepted forms of clinical knowledge embodied in 
medical literature and disseminated by healthcare professionals. Instead, those become part, but not 
all, of the basis for the knowledge collaboratively built within the PLM ALS group. 
METHODS 
Data Source: PLM/ALS Discussions 
The current study focuses on a qualitative analysis of the ALS community within PLM. The 
PLM-ALS community allows its members to interact and discuss various topics associated with 
ALS, and participate in research studies (Bedlack, Wicks, Heywood, & Kasarskis, 2010; Turner et 
al., 2011; Wicks, Massagli, Wolf, & Heywood, 2009; Wicks, Vaughan, Massagli, & Heywood, 
2011). Through research collaborations, PLM also permits analysis by researchers to uncover new 
findings that would be difficult to explore in traditional research studies (Frost, Okun, Vaughan, 
Heywood, & Wicks, 2011). This study analyzes a snapshot of data from PLM's ALS threaded 
discussion board, including 1000 messages randomly selected from a total of 2500 messages posted 
between February 2006 and November 2008. This time period coincides with the initial launch of 
the PLM-ALS community and represents a time when more active and concentrated knowledge 
sharing about this rare disease first took place among ALS patients and their caregivers on the web. 
Five coders coded 200 posts each from the full data set using initial codes created through an 
iterative and inductive process described in more detail in the next section. The data are 
characterized in Table 1.  
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[INSERT TABLE 1 HERE] 
Qualitative Data Analysis 
This project applied an inductive thematic analysis method to examine messages posted to 
the PLM-ALS discussion forum (Charmaz, 2006; Schrire, 2006; Strauss & Corbin; 1998). Codes 
for the data, used to describe the content, purpose, and context of each individual post, were 
developed through an inductive analysis of randomly-selected posts (Dickey, Burnett, Chudoba, & 
Kazmer, 2007). The authors developed the codes closely following procedures described by Dickey 
et al. (2007, p. 53): To begin, five coders individually examined 25 randomly-selected posts from 
the dataset without setting pre-defined categories. The authors then used an inductive, iterative 
process of discussion and additional coding to develop a list of codes to guide coding of the full set 
of posts. This ongoing process was also used to resolve disagreements about coding (Ahuvia, 2001) 
resulting in one consistent corpus of coded data (Bradley, Curry, & Devers, 2007; Steinke, 2004). 
Table 2 lists the final code categories and sub-categories that were developed through this process. 
[INSERT TABLE 2 HERE] 
*To save space, the full list of 117 codes is available on request from the corresponding 
author; the subsequent discussion takes into account the specific codes that were relevant to the 
conceptual lenses brought to this analysis. 
The concepts associated with distributed knowledge, undiscovered public knowledge, and 
authoritative knowledge were examined by focusing on interactions where participants were asking 
or answering questions for one another (distributed knowledge); where the level of authority held or 
perceived to be held by various people or information sources were different (authoritative 
knowledge); and/or where discussions occurred about topics that overlapped unexpectedly, where 
different posts shared content-related codes,  or when the conversation had included a connection 
between the topics in a way that revealed knowledge that was previously undiscovered. This theory-
driven approach to purposeful sampling of the data (Coyne, 1997; Patton, 2002) did not force a 
theoretical framework onto the data; rather, it allowed a means of access to a large dataset using 
codes that were based exclusively on the content of the posts.  
Knowledge shared across multiple participants (RQ1) was indicated by posts coded using 
the "purpose" codes listed in Table 3. Posts indicating authoritative knowledge and undiscovered 
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public knowledge literature (RQ2 and RQ3) were coded with "content" codes. The exchange of 
undiscovered public knowledge was reflected in the data through a set of codes that included 13 
codes associated with drugs and non-drug treatments (see Table 3). Similarly, authoritative 
knowledge phenomena were examined through a set of codes created for data mentioning care 
providers (also seen in Table 3). Additional combinations of codes indicated by the literature on AK 
and UPK were also examined. For example, co-occurrences of any other care provider code with 
neuro[logical] specialists were examined for their possible relation to AK, because neurological 
specialists have a high level of outwardly-perceived authority. Two codes to indicate cognate 
conditions that occur with ALS and that were broached as possible causes of ALS were used to 
examine aspects of UPK in posts focused on symptoms and pulled from threads related to drug and 
non-drug treatments. 
[INSERT TABLE 3 HERE] 
The codes were not used as restrictive criteria to determine which posts could and could not 
be examined. Neither did we cherry-pick only those posts and threads that seemed interesting, 
because all threads referenced by the codes listed above were examined. Rather, the coded posts 
were used as an entree to whole threads, and the content and coding of those threads led to the 
examination of related threads that also had distributed knowledge features. This illustrates the use 
of a second stage of purposeful (snowball) sampling through the data. The shift in unit of analysis at 
this point was intentional; while the data were originally coded at the level of the post, this analysis 
is explicitly at the level of the thread, allowing an examination of distributed knowledge across time 
and among multiple people. 
FINDINGS 
The findings are organized by the research questions posed above. Related phenomena 
identified in the background section are also explicated and supported by specific threads from the 
PLM-ALS discussion board. All posts are presented as originally written, including spelling, 
punctuation, and spacing; these "errors" in posts were common in the threads as PALS (persons 
with ALS) have varying symptoms that can make it difficult to type accurately, or they may use 
speech-to-text devices to produce their posts, which can also increase "errors." Individuals' names 
have been redacted and threads are identified by researcher-assigned letters for ease of reference.  
Distributed Knowledge in the PLM ALS forum 
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RQ1 asked: How and why is knowledge shared among the distributed participants in the 
PLM ALS threaded discussion forum? To address this question, we examined threads whose 
content was coded in ways indicating that knowledge was intended to be created and shared among 
multiple members of the community (see Table 3). A brief thread (seven posts over two days), 
Thread F, serves as a short and straightforward exemplar of distributed knowledge. It has the 
subject line "Loss of appetite from taking scopolamine," and includes contributions from five 
unique posters, all patients (rather than caregivers, family, etc.). This thread focuses on loss of 
appetite as a side effect of this medication. The original poster notes a loss of appetite after 5 weeks 
of scopolamine, and the thread focuses on resolving this side effect via the use of various 
cannabinoids (3 are discussed). In Thread F, the weight of the collective evidence from multiple 
users of different cannabinoids is brought together when one participant asks a question about loss 
of appetite.  
Knowledge can also be distributed: (1) across threads, as contributors refer to other relevant 
threads; (2) across participants with different roles (such as caregivers and patients); and (3) across 
time, as different threads are re-visited by new participants. An example of all three activities is 
found in Thread A, which has the subject line "Alternative – No Drugs." A caregiver begins Thread 
A, which comprises 10 posts, including contributions from nine different patient posters. The thread 
originally included four posts in three days and is re-visited by new participants eight months later. 
One poster connects the knowledge shared here across threads by pointing to related discussions 
elsewhere within PLM about "zero meds" and "not taking anything."  
The subsequent sections discuss knowledge building processes within the PLM-ALS 
community that are associated with undiscovered public knowledge and authoritative knowledge. 
Undiscovered Public Knowledge in the PLM ALS Forum 
RQ2: How do the participants in the PLM ALS threaded discussion forum work together to 
discover knowledge about treatments and progress in symptoms and to keep knowledge discovered 
over time? To address this, we examined posts focusing on treatments, symptoms and disease 
progress, specifically those referring to drugs and non-drug treatments, and to cognate conditions 
co-occurring with ALS or broached as possible causes of ALS (Table 4). These posts (and their 
threads) demonstrate some phenomena of UPK not exclusively related to discoveries from 
published medical literature.  
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[INSERT TABLE 4] 
Discovering public knowledge about ALS 
UPK phenomena were indicated in these posts by knowledge shared or created that 
reinforces or refutes other knowledge or that fills an expressed gap in knowledge, and that posters 
co-created out of their individual experiences. In Thread C a PALS asks about the relationship 
between anti-depressants and insomnia, acknowledging a gap in her knowledge that she hopes can 
be filled by others in the community:  
I have had ALS for 2 years now.[...] I have been trying to avoid an anti depressant but am 
changing heart. A week ago I got a prescription for Celexa and after one day stopped 
because I could not sleep. I took the Celexa in the morning but I still could not sleep. I will 
try again but does anyone have any suggestions? 
A PLM staff member responds that insomnia is "a known side effect of this drug" and 
recommends that the original poster talk to her doctor about other drug treatments for her 
depression, but adds: "It's quite possible that thinking about the effects of the drug lead to you being 
anxious, leaving you unable to sleep. I wouldn't have thought a single dose could have such an 
effect." The original poster responds explaining that for her, an anti-depressant is not worth 
increased insomnia because since her ALS diagnosis she has had insomnia that she treats with 
supplements (melatonin and valerian) and sleep positioning (hospital bed and pillows). She again 
asks specifically for input from other patients (rather than PLM staff), saying "I was curious to what 
other PALS take and if the insomnia was common for them and if it subsided after taking it for a 
while?" Contributions from PALS in the subsequent conversation include information about 
alternative anti-depressants and separate medications to fight insomnia; reinforcement of the 
knowledge that ALS often co-occurs with insomnia anyway; and that "older" anti-depressants and 
relaxants can be viable options to newer drugs. A brief dialog between two PALS explores the 
possibility of finding an anti-depressant that does not interfere with lithium: one PALS says "I take 
effexor without it Iam a real fu**ing jerk.they just make thinks easyer. but when i was onn lithium 
the lithium made the effexor not work so i stopped lithium wish find something that worked 
together", and another responds "I take Lexapro long with Lithium, have no side effects!" 
Throughout this thread multiple PALS work to discover possible solutions for "known" problems, 
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that is: that insomnia co-occurs with ALS; that depression co-occurs with ALS; and that anti-
depressants can cause insomnia.  
In Thread D, five PALS share their individual experiences with Baclofen, which is used to 
treat spasticity. The thread demonstrates how they work together to sort out contradictory and 
complex interactions between the side effects and delivery mechanisms of this drug. The original 
poster summarizes his experience and explicitly seeks experiences from other PALS: 
I was put on baclofen 1 pill a day.. Symp. got worse. Doc upped to 3 a day...worse yet..Doc 
upped to 5 a day.. I could not breath, walk, and weak as hell.. Wife cut back to 1 a day.. all 
symp. went away but the ache in my legs.. I thought it was the als.. It was the damn 
baclofen..Anyone else have this? 
The second poster responds by indicating that the reaction described by the original poster is 
"known" to her, sharing her own experience with baclofen and another anti-spasticity drug: "I have 
heard of this reaction before. [...]Talk to your doctor. I tolerate baclofen very well and I am taking 
around 90 mgs. a day. It helps with the pain and spasticity in my legs. I also take Zanaflex which 
helps the best in addition to the baclofen." The third poster offers his individual piece of knowledge, 
saying, "It made me feel the same as you. I took it a few days and stumbled around, slurred speech 
even more, just a general feeling of increased weakness all over. If you think about it, it makes 
since. Baclofen is a muscle relaxer." The fourth poster adds another piece to the knowledge mosaic, 
suggesting that an alternative delivery mechanism (pump rather than oral delivery) might have "far 
less if any at all side affects." The final poster adds the last piece in direct contradiction to the 
previous post in favor of the pump. This leaves an overall impression regarding the lack of 
consensus in the available public knowledge about this treatment. The sharing of these individual 
cases illustrates the discovery of public knowledge but also demonstrates the complexity and non-
absoluteness of knowledge" about treatments: 
Hi,I had a horrible reaction to the baclofen pump!! I walked in the hospital using a walker 
the day of surgery and I could get up from a sitting position. After surgery I came home that 
night I couldn't move my legs at all[...]. Off to the ER[....] After 16 hours the pump was 
turned off, 10 days flat on my back with the worst headache ever, 4 months of PT, I used a 
walker about a year afterwards. I never was able to get up from sitting again and 6 years 
later the pump is still in me not running. Beware of the pump!!!!!!! 
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Thread D (above) illustrated how discovering knowledge is not always a straightforward, 
linear process. Knowledge can remain undiscovered for various reasons even though it is likely to 
exist elsewhere or knowledge can be discovered by accident. Two more threads, both of which deal 
with the topic of frontotemporal dementia (FTD), demonstrate these features of knowledge 
discovery. Thread L begins with a PLM staff member posting the abstract of an article called "A 
screening assessment of cognitive impairment in patients with ALS." The thread takes a turn when 
several patients bring up the issue of their lack of access, or perceived lack of access, to the medical 
research literature (due to cost and language/writing/jargon). The PLM staff member subsequently 
posted: "You can subscribe to the jounral here [hyperlink provided in original] but it is nearly $300 
a year and is of course written in scientist language. Much of the most interesting ALS research is 
press-released by ALSA/MNDA/MDA/TDI anyway in much more accessible language." In 
response, a PALS writes, "I would politely dissent a bit on the value of the journal (expensive as it 
is) for non-scientists. Some of the articles on psychology and the emotional health of patients are 
easy enough to understand and the abstracts and discussion sections in most of the higher levels 
articles can be grasped by laypeople." This thread provides several examples of, and possible 
reasons for, a known lack of discovery. PALS indicate a shared understanding that cognitive 
impairment co-occurs with ALS for some patients. However, research on cognitive impairment 
among PALS lags because most are focused on causes and treatments of ALS; because screening is 
more difficult (for example, as explained by the original poster, because "cognitive problems are 
clouded by communications problems,"); and because some findings about the brain (for example 
about proteins in the brain) are based on post-mortem pathology rather than on "collecting samples 
from recently diagnosed patients to ensure we're getting proteins from around the time of clinical 
presentation" (see also Wicks & Frost, 2008). 
Analysis of Thread K echoes what was discussed in Thread L (above) -- that the 
manifestation of FTD in PALS remains largely undiscovered. The original poster, a PALS, shares 
coping strategies, information on the medications he/she uses, and an outside source (web site) on 
FTD. The second poster asks: "i wonder if, once you have FTD, you can objectively diagnose 
yourself"? This post is misunderstood as a joke that is making fun of the original poster and the 
member who asks the question returns to say, "i AM asking a serious question! will we know when 
we have it?" Despite the misunderstanding and the resulting 6 posts in which participants do the 
emotional work of settling the conflict, the thread opens up a discussion about FTD and its co-
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occurrence with ALS. A final poster ends by saying: "Thanks for giving an insight into your 
situation and opening a very neglected area." 
Thread K also demonstrates how a piece of public knowledge unrelated to FTD is 
discovered through the conversation. In the third post in the thread a PALS responds, "I laughed so 
hard reading this that I spit out the beer I was drinking and nearly peed my pants! Why don't you 
post the questionnaire for FTD so we can all self diagnose - then, we'll get back to you (or, not)." 
The problem of incontinence, expressed however facetiously in this post, results in a backchannel 
private message communication -- the poster subsequently makes public the resulting knowledge 
discovery by editing their post: "**update: I was just advised via pm [private message] that FDS 
[feminine deodorant spray, http://www.fds.info/faq/] will help with peeing pants. I didn't know what 
that was. It's "female deodorant spray"." 
Maintenance of discovered knowledge 
Two short threads exemplify the challenges of keeping public knowledge discovered within 
the PLM-ALS community. Thread P illustrates what happens when knowledge discovered is not 
discussed or evaluated by the community. In essence, the value of this discovered knowledge 
remains unknown if it is not accepted by the community through use and preserved (in the case of 
PLM, the official PLM list of ALS symptoms serves as a proxy for this representation and 
preservation of discovery). The original poster in Thread P thinks his front teeth are eroding but is 
not certain. Several follow up posts share potential causes (sweet drinks, hard straw, 
grinding/clenching, teeth-shift caused by ALS) but no solutions, and the original poster never 
returns to the thread to clarify or verify symptoms. The idea that teeth shifting may be part of ALS 
is evidently a discovery, at least for this subset of the community. But unlike most other threads, 
there is no resolution, no concrete suggestion, no reference to the literature, and no suggestion of 
adding a symptom to PLM's official ALS symptom list – so the discovery is not preserved. 
Thread B exemplifies a situation in which public knowledge that is already known to be 
discovered has trouble staying discovered. The original poster experiences itching and wants to 
know if it is normal for ALS. Subsequent posts by other PALS and PLM staff imply that itching as 
a symptom of ALS is public knowledge in this community but the original poster points out, "I am 
writing about itching because i don't see the itching in the <symptoms>." A PLM staff person 
responds that one can search the "symptoms" discussion and find information about itching. 
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However, its absence on the list of symptoms demonstrates that itching has not (yet) been codified 
as an official symptom within this community and therefore still requires “discovery” by members 
not familiar with this. 
Authoritative knowledge in the ALS forum 
RQ3 asked: How do participants in the PLM-ALS forum co-create and treat authoritative 
knowledge from multiple sources including the medical literature, health care professionals, lived 
experiences of patients, and "other" sources of information such as lay literature and alternative 
health providers? To address this question, we examined posts that include or refer to the opinions 
of individuals with 'externally-perceived high authority' (neurological specialists) and individuals 
with 'externally-perceived low authority' (alternative and natural medicines), and that include 
references to other resources pointed to as providing or proving authority of knowledge (Table 5). 
This approach is not meant to assert an objective view of authority that reflects the opinion of the 
researchers or the PALS, but instead refers to Jordan's (1997) original formulation of authoritative 
knowledge where there is an understood hierarchy that is not necessarily accepted within a specific 
setting.  
[INSERT TABLE 5] 
Co-constructing authority by collecting personal experience 
Three threads (N, G, and M in Table 5) help to demonstrate this community's preference for 
personal experience as evidence in their co-construction of authoritative knowledge, and what 
happens when personal experience interacts with other forms of knowledge considered in society 
(and particularly by health care professionals) to be "authoritative."  
The topic of Thread N is IVIGlobulin therapy, and it begins with a brief query: "Has anyone 
participated in IVIGlobulin Therapy and if so, has there been any improvement from this 
treatment?" The remaining posts of the thread work together to paint a coherent picture of IVIG as 
an effective treatment for multi-focal motor neuropathy (MMN) but not ALS. MMN can be difficult 
to distinguish diagnostically from ALS in its early stages. The efficacy or non-efficacy of IVIG can 
be used diagnostically; if it is not effective, then the diagnosis is more certainly ALS and not MMN, 
as demonstrated by this post: "My first dx [diagnosis] was Multifocal Motor Neuropathy (MMN) 
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and I did 5 days straight of IVIG. When nothing happened, my doc reconsidered my dx and 
changed it to ALS."  
This thread illustrates how experience and medical literature offer different forms of 
evidence when building authoritative knowledge in this community. As noted in the thread about 
no-drug approaches to ALS (Thread A), personal experience (as distinct from opinion) is a form of 
knowledge that this community has mutually constructed as being authoritative. This was also 
demonstrated from the opening of this Thread N, which begins "Has anyone participated...." Five 
PALS who had tried IVIG provide answers, and three of them post again to share more details of 
their direct experiences. Six posts by one individual (who is not a PALS and who otherwise does 
not participate in the thread) referred largely to outside authority, citing medical research articles 
and attempting to provide additional contextual authority for the medical research articles by 
including their PubMed ID numbers and full citations. This contributor does not interact directly 
with any PALS in the discussion and the discussion among the PALS begins again three months 
later with another set of four posts. These latter posts do not refer to the six medical research posts 
but start by sharing more personal empirical experience: "I've had four courses of IVIG, and it 
seems to help. I had my best reaction to the first round. I was diagnosed with ALS, but after a spinal 
tap and the IVIG, I've got two neurologists saying that I don't have ALS, and that I probably have 
MMN." In addition, this set of posts revisits the role of IVIG as a diagnostic indicator, where the 
treatment's efficacy is indicative of MMN rather than ALS. The shift back to personal experience 
posts without any reference to or acknowledgement of the six mid-thread medical literature posts 
should not be taken as an indicator that outside medical authority is entirely meaningless to these 
posters. It does imply that it is of less importance to the community's construction of authority 
compared to the knowledge embodied in personal experience. In fact, the second post in the third 
group includes this passage in which the poster refers to the existence of a hierarchy of authority: 
"My treatments did absolutely nothing for me and gave my doc his first suspicion of ALS. I'm no 
doc but, if you got results from IVIG, you don't have ALS." It is not possible to tell from this 
passage whether the poster truly believes his/her knowledge is less authoritative than that of a 
physician, as it could be interpreted in several possible contradictory ways. Nevertheless, inclusion 
of the clause "I'm no doc" alludes to the shared understanding that a hierarchy exists, although it is 
less meaningful within this community than it is outside.  
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Thread G also demonstrates this community's preference for personal experience as 
evidence. Thread G begins with a request from a PALS for PLM to develop a "rated list of MDs"; 
the initial post goes on to say: 
It would be a valuable service if this forum could legally compile a listing of MDs rated by 
whether they are willing to "aggressively" treat ALS, or whether they stick to the Rilutek 
cookbook, or whatever other adjectives you might choose. Proactive MDs are needed who 
will prescribe off-label (but still do all the monitoring, etc.). A lot of neuro's become 
irrelevant to a large degree once a dx is made if all they do is prescribe Rilozole and 
"manage the disease's progress". Given the internet and forums like this, most PALS know 
as much as their neuros, at least as far as knowing the CAUSE, the CURE, and the 
TREATMENTS. If MDs expect to be part of the solution, they need to try new approaches 
and stop just waiting for the researchers to discover THE pill. 
As a side note, this post also highlights a common theme in medical support groups, that 
"expert patients" often know as much as their specialist physicians do about their conditions 
(Brownstein, Brownstein, Williams, Wicks, & Heywood, 2009; Hartzler & Pratt, 2011). The 
remainder of the thread focuses on whose knowledge about the MDs is considered authoritative 
within this community. It suggests that in this community the patients are the ones with that 
knowledge: as the thread originator says in a subsequent post, "it's about personal experience - no 
one else could do it [rate the MDs] but the 'user'." It is agreed throughout the thread that this 
knowledge needs to be shared anonymously because the same power structure that affords MDs 
more outwardly-perceived "authoritative knowledge" than lay experts also makes the patients 
vulnerable to negative consequences. None are explicitly listed in this thread but possible negative 
consequences include the MD losing trust in the patient, the patient/MD relationship suffering, or 
the MD refusing to treat the patient further (Brody & Haut, 2009; Wright, Nyland, Carnevale, & 
Gros, 2010).  
Thread M, although brief, serves as a good example of how members value personal 
experiences as evidence while not wholly dismissing the knowledge of health care providers. In the 
first 10 posts, different PALS indicate that they had no experience with the specific type of "colon 
cleanse" that is mentioned in the original post. In the eleventh post, another contributor indicates her 
willingness to be a "guinea pig" and try the colon cleanse program, saying "I will update here." 
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After three months, a new contributor asks, "Just wondered how your cleansing went. Did 
everything come out OK?" The PALS who volunteered to do the cleanse responds: "I didn't do the 
cleansing. I emailed my GP and he said the most the cleanse would do is give me diarrhea. Getting 
to the toilet is hard enough as it is, let alone having diarrhea too." The remainder of the thread 
includes it getting "bumped" (a common mechanism in discussion boards used to maintain 
knowledge among the group by moving an existing thread into the current, active discussions) and 
then two new posters ask: "has anyone tried this?" and "Holy crap! Has anyone tried this particular 
program? If I have anything like that in me, I want it out! Seriously, I think colon cleansing sounds 
like a good idea for anyone. I would like to know what products or ingredients have been used and 
how well did they work." There are no subsequent posts, but the desire for personal evidence is 
clear throughout the thread. It is also clear that the poster who volunteered to test the cleanse, and 
provide the personal experience so valued by this community in their constructions of authoritative 
knowledge, relied on knowledge from her GP to make the decision not to test the cleanse.  
Co-constructing authoritative knowledge by seeking widely-varying outside sources  
There is no generally-accepted known cause of ALS, but the topic is sometimes discussed in 
the PLM-ALS community. This is one topic where direct experience (normally considered so 
important in determining authoritative knowledge in this community) is of less importance because 
no one person has the answer. Close examination of three threads (Threads H, J, and E in Table 5) 
provides multiple examples of how members work to co-construct authoritative knowledge by 
seeking evidence from various sources with different perceived kinds and levels of "authority." In 
Thread H, the original poster asks, "With all this floundering about for decades on the cause of 
ALS, why isn't it understood that the most likely cause of a neurological disease is a neurotoxin?" 
The poster has framed the post as a question, but is presenting an opinion (that ALS, being a 
neurological disease, is most likely caused by a neurotoxin) and is tacitly asking the group why that 
opinion is (a) not more widely held and (b) not being pursued by medical researchers. The second 
poster responds with an acknowledgement but also a hedge against the absoluteness of the 
neurotoxin hypothesis: "I have to agree with you. Neurotoxin and metabolism unique to a particular 
person." The original poster responds:  
So, if that's a given and it's strongly suspected that some forms of als have environmental 
triggers, then why aren't neurotoxins being looked at more closely along with their presence 
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in the body and our ability to rid ourselves of them? A lot of what's being studied is in my 
opinion the downstream results of neurotoxins and Phase 2 being out of ratio with Phase 1. I 
mean, just mention something as simple as Phase 1 or 2 detox pathways and eyeryone says 
"Huh?" Could it be as simple as that? Am I not making sense here? I'm just a simple guy but 
Yikes! 
This response demonstrates authoritative knowledge concepts in several ways. The poster 
uses the word "everyone" to lend authority to his hypothesis -- bringing in the collective weight of a 
number (rather than the status) of unspecified others. The poster also uses words ("I’m just a simple 
guy") whose explicit meaning downplays his own authority but carries weight in this community, 
which values the authority of the layperson. The remainder of the thread brings in more possible 
causes of ALS, and different kinds of references to authoritative sources to give weight to the 
shared knowledge and to buttress different suggested causes (e.g., "articles I have read," an MD by 
name, a Google search, and the BBC news). Posters provide a wide variety of answers supported by 
a wide range of “authoritative” sources making this thread different from other topics discussed in 
this community where authoritative knowledge is normally co-constructed out of personal 
experiences and (to a much lesser extent) from medical research and specialists.  
A similar process is seen in a related (not explicitly linked) thread, Thread J. The original 
poster asks others to share "what you think is the most likely trigger of your ALS? Even if there is 
no obvious trigger, please state that too" and indicates their own alignment with an (as of yet) 
unspecified hypothesis that head trauma can cause ALS:  
I think my onset is 2 months after I was "hit" on the back of the head/neck using cupped 
hand repeatedly (about 30 times ) by my massage therapist, supposedly to release tension. 
He used the force about the same as clapping hands. I did not feel much pain. That is the 
closest "head trauma" that I can think of. 
The original poster, later in the thread, provides support for the head trauma hypothesis by 
sharing a news story (published in a mainstream newspaper) that explicitly links one person's death 
from ALS to a specific head trauma. Other PALS resist this hypothesis and respond by posting 
things such as: "Dont search for a trauma, for me its the genetic"; "Wouldn't there be a more 
medically recognizable connection?"; "it's easy to look back and find suspicious incidents in 
anyone's past...I give my history to my doctors and other researchers and let the professionals try to 
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figure it out while I get on with enjoying the heck out of life"; "a world-renowned expert in ALS, 
said the link between trauma and the onset of the disease may be 'tenuous,'"; and "My specialist said 
that the trauma of prostate cancer in june 2004 could have triggered ALS" (which aligns with a 
trauma hypothesis but not specifically head trauma). The latter four of these excerpts explicitly rely 
on medical professionals to lend externally-perceived authority to the as-yet-undetermined causes of 
ALS. Interwoven in the discussion are posts from long-term PALS providing their own 
authoritative knowledge (authority earned by the length of time they have lived with the disease) 
about the futility of a lay approach to a search for causes and the need to focus on enjoying life 
while letting researchers solve the problem. This viewpoint is both tacitly and explicitly indicated in 
posts such as these: "After 21+yrs with ALS I don't even bother myself worrying about what 
triggered mine. I just take one day at a time and try to make every day special in some little way"; "I 
refuse to dwell on it, or have self pity. I try hard to live as normal as possible. My husband thinks 
I'm in denial, and it drives me insane! After 10 yrs of this, there is no denying"; and "I have no 
concrete explanation for my having ALS. It may have been the massive dosages of chemotherapy I 
received 15 years ago. It may have been the back trauma I suffered in years prior, or environmental 
exposures. Whatever the causes, the point is to make the most of what we have now." 
Another thread that seeks authority from a wide variety of outside sources is Thread E, 
which discusses a potential and controversial treatment for ALS involving glutathione (an 
antioxidant normally used as a supplement rather than a medication). The original post is long (484 
words), and the poster supports his pro-glutathione content by drawing explicitly on the authority 
vested in: his personal experience with therapy with glutathione (a lack of ALS progression when 
he was taking it and a return of progression when he stopped taking it), published literature on ALS, 
his own physician, his naturopath, German colleagues of his naturopath and the experiences of their 
patients, and God. The next eight posts are a dialogue between the original poster and one other 
PALS, who expresses his belief that money (which carries its own authority) is an important factor 
in determining which potential treatments are and are not pursued by medical researchers: "it's 
logical for there to not be much interest in this line of thought. Not that Doctors and drug companies 
aren't well meaning, but lets face it, the almighty dollar drives everything." The tenth post in the 
thread is from a PLM staff member asking any PALS with experience with glutathione to share 
those details within the PLM site. This demonstrates an attempt to derive authority using a more 
"standard" research approach, that is, to establish reliability across a larger "n" and through use of a 
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standard rating scale: "If anyone else is taking it then please enter your details onto your profile and 
in future I may be able to find out if it is having any sort of consistent effect." The relative weight of 
different personal experiences is brought into play when another PALS finds a way to tacitly 
contradict the original poster without arguing with him but rather by bringing the authority of their 
own experience: "My experience with IV Glutathione was far from what you are experiencing. I 
was in a safety trial with 4 other PALS. We took it IV twice a week for 4 months. I felt no 
difference, better or worse." 
DISCUSSION 
The online discussion among members of the PLM-ALS community demonstrates various 
phenomena associated with distributed knowledge, undiscovered public knowledge, and 
authoritative knowledge. While it exists as a support group for people who share a medical 
condition, PLM is also intended to be a rich arena for knowledge creation, sharing, and 
preservation. As this analysis indicates, members of this online community engage in the 
construction of distributed knowledge in order to better understand their disease and to find better 
ways to cope. PALS come together to provide collective evidence, mostly from personal 
experience, and to help each other to understand these important issues. Users also create 
connections from thread to thread in order to facilitate the discovery of knowledge for the group, 
particularly as topics often need to be re-established when new users join the group. 
With regard to undiscovered public knowledge, varying bounds of what can be defined as 
discovered are also indicated by these data. Knowledge can be discovered locally rather than 
universally; for this group, discovery within the context of the PLM/ALS environment is often 
sufficient for their personal purposes. The discussions show that knowledge does not have to end up 
residing with one person to be discovered, a distinction that means persistently distributed 
knowledge can then be considered discovered. When people who are not co-located interact online, 
knowledge is not only distributed across space, it is also distributed across time as discussions are 
conducted asynchronously. Our analysis shows that knowledge is also distributed across time in a 
much broader sense; this is how knowledge is maintained and refreshed in the long term. When new 
members join the community, they not only bring new knowledge, but they introduce gaps in their 
knowledge that may have already been previously filled and addressed within the online 
community. Part of keeping knowledge discovered is to bring new people into the group and 
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facilitate their acquisition of existing knowledge. This can be difficult because it is not reasonable to 
expect them to "just read the whole archive" because there is too much material there, not 
everything is relevant over time, and some knowledge evolves because accepted knowledge (see 
also authoritative knowledge) changes. For any new member, then, there is a process of what 
knowledge needs to come forward, when, and in what context. This is partly decided by people -- 
generally those who have been there longer (participants or administrators) or who have some 
important kinds of knowledge (i.e., content knowledge previously discussed, location knowledge of 
where it is and how to find it, and the understanding of the timing and flow of the community to 
know when it needs to be moved forward again). It is also partly decided through technical 
affordances of the system that allow people to manipulate knowledge through time: search 
capabilities, the ability to "bump" older threads into the active discussion, and the ability to generate 
lists of symptoms and treatments maintained by PLM. When all of this works well, knowledge gets 
distributed across "long time" (as distinct from the "short time" distribution during the life of a 
thread), thus maintaining the knowledge of the community in important ways: knowledge is less 
likely to get lost; experienced users are less likely to get frustrated by the repetition of existing 
discussions; and old discussions can be refreshed purposively and when needed rather than 
occurring automatically and in a contextual vacuum. 
Authoritative knowledge (AK) is constructed by members of the PLM-ALS community by 
navigating between the authority claimed by PALS based on their lived experience and that of 
medical providers and researchers whose authority is externally vested on them by their positions, 
medical credentials and other evidence of their expertise or areas of specialty. Medical professionals 
have the knowledge that "counts"—what is generally accepted as true—and what is considered 
actionable in terms of what is acceptable to say in public, and what allows one to legitimate actions, 
such as taking medication, selecting assistive devices, filing insurance claims, and so on. The 
concept of the expert layperson is important here because many ALS patients become experts in the 
disease or in aspects of it that affect or are of interest to them. No matter how much knowledge they 
develop over time, it will not be authoritative if the group does not define it as actionable or 
acceptable. Shared knowledge by multiple people, especially those with personal experience, lends 
the weight of collective evidence. 
In an ill-defined knowledge area such as that surrounding ALS, where causes and treatments 
are unknown and imperfect, efforts to share, discover and create knowledge rely on evidence for 
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authority as well as more traditional hierarchies and accepted values of knowledge. Even if a cause 
(or partial cause) of ALS is discovered (e.g., Siddique & Ajroud-Driss, 2011) this finding is relevant 
for the many diseases whose causes remain unknown; the activity of seeking causes among fellow 
patients, even if it does not generate a factual result, fills a need and provides patients the 
opportunity to share knowledge and to share emotional support.  
LIMITATIONS 
A few limitations of this study must be noted. The researchers were granted access to a 
randomly-selected subset of threads from the PLM-ALS community. While the sample size was 
large and allowed the researchers to examine complete threads, we could not realistically examine if 
threads were revisited after the sampling frame, and it would not have been possible to compare the 
content of the analyzed posts with those of other communities, or over a longer period of time. The 
data collected were created at a specific moment in time soon after PLM first went online, when 
knowledge discovery and authority construction were new in the community. Technologies used by 
PALS will change over time, but the findings here are focused on knowledge creation and discovery 
rather than technology use.   
Second, the data received from PLM were de-identified in order to protect their users. 
Generally this was not an issue in coding data for this study but user expertise in the form of 
educational or work background could not be examined (data which PLM was not capturing at the 
time of data export anyway). It was possible that a user could be a PALS yet also be a member of 
the medical community. Although this information was not crucial to analyzing authoritative 
knowledge, it may have been helpful for understanding the community more.  
A third limitation is that it is very difficult to assess undiscovered public knowledge because 
it is just that, undiscovered. Although the threads indicate that as users share new information with 
each other based on their own experiences or acquired knowledge, without the input of an expert it 
is hard to make the leap from true undiscovered public knowledge to a known truth.  
CONCLUSIONS AND IMPLICATIONS 
The focus of this study was to examine distributed knowledge-building within the PLM-
ALS community -- an active and engaged community with a shared interest in understanding a rare, 
progressively debilitating, and currently incurable disease. The unconstrained ability of distributed 
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participants to post to the online community at any time of day allows for the examination of 
knowledge building processes in a setting that has few bounds of time or space. The PLM-ALS 
community is an ideal arena to examine the phenomena associated with distributed knowledge 
building and specifically related to the subcategories of undiscovered public knowledge and 
authoritative knowledge within a health context.  
We coded and analyzed 1000 posts from PatientsLikeMe, an online community of patients, 
caregivers and others touched by ALS. In addition to being a source of social support, the site 
provides a forum for users to share information, discuss ALS, and build knowledge of the disease so 
that they can make better informed choices about their treatment, lifestyle, and future plans. We 
examined this data from the lens of distributed knowledge concepts, leading to insights about how 
members of the community co-construct knowledge, the processes undergirding their discovery of 
knowledge related to ALS, and their experiences navigating the complex knowledge environment of 
the patient and medical infrastructure.  
The strength of this study lies in its implications for theory and research. The analysis 
provides evidence that patients and their caregivers use online tools to build and discover 
knowledge about a shared medical condition, seeking and providing answers and benefiting from 
the personal experiences of many other patients while giving comfort to others touched by the same 
medical ailment. Features of online support groups that allow sharing of knowledge across time and 
space can facilitate knowledge building and discovery but can also pose challenges for “preserving” 
these discoveries. For example, the analysis indicates that as more members are added to a group or 
as more information is shared over time, the discovery of public knowledge is not only enhanced 
but it can also be hindered without processes in place to help participants make connections 
between disparate pieces of knowledge. Moreover, the findings indicate that discovering knowledge 
does not appear to be as difficult as keeping it discovered.  
The study sheds light on how patients’ perceptions and practices about evidence and 
authority behind knowledge can affect their treatment decisions. The study reveals that people seek 
out not only understanding and support from those who share their illness, but also authoritative 
knowledge from experts or others deemed more knowledgeable than themselves. The findings 
suggest that PLM-ALS members provide information that complements knowledge gathered from a 
wide variety of sources. At the same time, the analysis indicates that authority is claimed and vested 
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through different mechanisms but most prominently, in this environment, through personal 
experience. Patients develop expertise (Hartzler and Pratt, 2011) about daily treatment practices 
through trial and error and can therefore share valuable information and actionable advice based on 
their lived experiences, thus co-contructing authoritative knowledge among the patient community. 
This is particularly valuable in areas where there is limited empirical evidence and when many 
aspects of disease treatment and management are still poorly understood.  
While past research has connected distributed knowledge building to information retrieval 
systems (see, for example, Hoadley & Kilner, 2005), this paper was not specifically focused on the 
design of online community systems. However, this is an area of interest and the findings of this 
study do have implications for system design and can provide guidance for future research. For 
example, researchers in this area may want to look closely at how system design influences 
distributed knowledge, and how system features can provide support for discovering the 
undiscovered, navigating the complex area of authority, and keeping knowledge discovered over 
time and across people. As such, the findings may be used to inform future efforts to design more 
effective online health communities, encourage experts to join online health communities and stay 
active in the group, as well as motivate users to seek and post information from other sources 
(online and offline).  
Overall, these results indicate some of the practices employed by online community 
members to build shared knowledge of their disease. Results from this study provide theoretical 
support for research on distributed knowledge and inform builders of online health communities 
about how to better support knowledge sharing among its members. Alternatively, tools for 
streamlining these knowledge-sharing processes may help hasten the discovery of treatments or 
better ways to help patients manage their conditions and alleviate stressors associated with rare 
diseases. 
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Table 1. Posts per individual and per thread in the 1000 posts analyzed. 
Posts per individual (n=241 individuals) 
Range Median Mean 
1-76 2 4.3 
Posts per thread (n=85 threads) 
Range Median Mean 
3-48 7 12.2 
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Table 2. Final code categories and sub-categories used for all coding*. 
# of codes Within the Category Divided into Subcategories 
Help self Help others 15 "Purpose" 
Referring to PLM Misposted/empty post 
18 "Miscellaneous" Signatures Language use Topic drift 
Equipment Drugs 
Treatments (non-drug) Activity 
Policy Experience with ALS 
Care providers Emotions 
84 "Content" 
Coping mechanisms Other content 
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Table 3. Existing codes used to begin the purposeful data sampling process. 
RQ1: "Purpose" codes  Example threads/quotes  
1. Ask a question  Thread F: "You drink pot? What are you taking?" 
2. Answer a question Thread A: "I'm not on any Rx right now. I don't necessarily go out 
of my way to avoid them. I also do not like that “drugged" feeling." 
3. Supply factual 
information 
Thread H: "Neurotoxins are cause by Microorganisms. I have read 
articles that said that 90% of the neurotoxins come from the food we 
eat. In 2000 a Dr. Ritchie Shoemaker MD. come up with a Visual 
Contrast Sensitivity Test to reveal the presence of neurotoxin in a 
patients system. The test only takes 5 minutes." 
4. Direct users to PLM 
resources 
Thread E: "FYI, click here to find out more about this treatment. If 
anyone else is taking it then please enter your details onto your 
profile and in future I may be able to find out if it is having any sort 
of consistent effect." 
5. Direct users to other 
resources 
Thread N: "Here is some info on this topic. Note this passage:"... 
IVIG was not recommended for 8 conditions including 
adrenoleukodystrophy, amyotropic lateral sclerosis, autism, critical 
illness polyneuropathy, inclusion body, myositis, intractable 
childhood epilepsy, paraproteinemic neuropathy (IgM variant), and 
POEMS syndrome." Transfus Med Rev. 2007 Apr;21(2 Suppl 
1):S57-107." 
RQ2: "Content" codes Example threads/quotes 
1. Prescribed drugs 
  
Thread C: " I take 40 mg. of Celexa and it is of great assistance in 
keeping me balanced emotionally. The "start-up" period for many 
antidepressants can cause side effects, for me the only bad start-up 
side effect I got from Celexa was nausea, which disappeared after a 
few days. The main side effect with SSRI's is loss of sexual libido. I 
also have had problems with insomnia, dating way before I was 
diagnosed with ALS. An antidepressant I've been given which is 
very sedating is Remeron (mirtzapine), however this drug has a side 
effect of weight gain. I've also taken Ambien and Lorazepam 
(Ativan) on occasion." 
2. Over-the-counter 
drugs 
Thread B: "My wife found an anti-itch ointment at Target that 
helps." 
3. Drug trials Thread E: "My experience with IV Glutathione was far from what 
you are experiencing. I was in a safety trial with 4 other PALS. We 
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took it IV twice a week for 4 months. I felt no difference, better or 
worse. This was back in 03 and I think I'm the last of the 4 of us still 
kicking." 
4. Alternative 
medicines/natural 
remedies 
Thread C: "I am also taking Melatonin and Valerian (an herbal sleep 
rejuvenating sleep supplement)." 
5. Supplements Thread S: "Hello pals,I noticed several of us are taking Coq10, 
fishoil, grape seed extract and creatine. I recently started taking 
Coq10 and I was very dismayed at the steep prices of these 
supplements at GNC. I wanted to know if anyone taking these 
thinks if they're doing any good. I know in theory they're suppose to. 
I feel the Coq10 has helped me, but that might be psycological. I 
would appreciate any input. Thankyou." 
6. Drug side effects Thread D: "I was put on baclofen 1 pill a day.. Symp. got worse. 
Doc upped to 3 a day...worse yet..Doc upped to 5 a day.. I could not 
breath, walk, and weak as hell.. Wife cut back to 1 a day.. all symp. 
went away but the ache in my legs.. I thought it was the als.. It was 
the damn baclofen." 
7. Drug interactions Thread C: "I take effexor without it Iam a real fu**ing jerk.they just 
make thinks easyer. but when i was onn lithium the lithium made 
the effexor not work so i stopped lithium wish find something that 
worked together." 
8. Drug efficacy Thread T: "I have excess saliva but not as serve as you report. My 
doctor prescribed HYOSCYAMINE, 1 teaspoon four times a day in 
my PEG TUBE. It is working fairly well. If I miss a shot the saliva 
increases." 
9. Physical therapy Thread R: "It takes a lot out of me when I go to my Physical 
Therapist. They insist I do bike riding for 15 minutes. I'm exhausted 
when I come home & have to sleep. I was wondering if that was the 
cause. I'd like to hear what others have to say about PT." 
10. Occupational therapy Thread U: "I cling dearly, to each wasting function and do not relish 
giving up any capacity, willingly. My occupational therapist advises 
me to get used to doing less and stop pushing myself; useful advice, 
as maybe: I am unable to oblige! Mentally and emotionally I need to 
keep trying to be as physically active as I can, without going to 
extremes." 
11. Diet and exercise Thread A: "Zero Rx meds for me. I do take supplements, CoQ10, 
vitamin E and C, multi vitamin and Melatonin at night to help sleep. 
Exercise/workout everyday." 
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12. Treatment costs Thread N: "My neurologist had me on IVIG for a year when he 
misdiagnosed me as having multifocal motor neuropathy with 
conduction block. Pretty expensive stuff. I was getting it every three 
weeks-$2500 a pop." 
13. "Other" (under 
subcategory Non-drug 
treatments) 
Thread P: "Yesterday I had four or five side teeth removed. ow! As I 
said in an earlier post, my lower teeth are horizontal, allowing the 
upper teeth to drill into the lower gum. I will return in two weeks to 
get the other side done. This shift in my teeth is definitely due to 
ALS. If you notice teeth shifting or a change in your bite, go to a 
dentist in a rehab hospital. Ordinary dentists won't know what to do. 
Perhaps teeth shifting should be listed under Symptoms." 
RQ3: "Content" codes  Example threads/quotes 
1. Neuro[logical] 
specialists 
Thread G: "A lot of neuro's become irrelevant to a large degree once 
a dx is made if all they do is prescribe Rilozole and "manage the 
disease's progress". Given the internet and forums like this, most 
PALS know as much as their neuros, at least as far as knowing the 
CAUSE, the CURE, and the TREATMENTS." 
2. General physicians Thread M: " I didn't do the cleansing, Dave. I emailed my GP and 
he said the most the cleanse would do is give me diarrhea.Getting to 
the toilet is hard enough as it is, let alone having diarrhea too." 
3. Family Thread E: "I am with you all the way. About 15 years ago my wife 
and I were involved in a herbal MLM that was promoting Colon 
Cleansing and later Liver Cleansing.We did the Colon Cleansing 
and WOW we were blown away with the improvements to our 
health and well-being." 
4. Friends Thread Q: "When my daughter was playing softball in high school a 
couple girls on the team hung around our house enough that they 
learned how to suction. If Deb was in the concession stand working 
and they heard my vent beep they'd come do it if they weren't in the 
field. A couple of my son's friends know how to do it too but only 
do so in case of an emergency. LoL." 
5. Professional for hire Thread R: "Next week I am to start some starter sessions using a 
motorised exercize cycle, to get some more movement in my legs all 
done from my wheelchair. The Rehab Nurse is going to visit me at 
home with a Physiotherapist to do a complete medical check to 
ensure I can indeed use this device without harm." 
6. Clinics Thread G: "I have been sorely disappointed in the ALS Clinic I go 
to for treatment. I don't really expect a cure but I am tired of being 
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written off!" 
7. "Other" (under 
subcategory Providers) 
Thread J: "I think my onset is 2 months after I was "hit" on the back 
of the head/neck using cupped hand repeatedly ( about 30 times ) by 
my massage therapist." 
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Table 4: PALS discussion threads referred to in findings about undiscovered public knowledge. 
Thread Subject line Total # 
posts 
# 
Posters 
Notes 
C Anti-depressants 11 9 Eight posters are PALS, one is 
a PLM staff member 
D baclofen 5 5 All posters are PALS. 
L New issue of ALS 
journal out today 
10 3 One poster is a PALS, one is a 
PLM researcher, and one is a 
friend of a PALS. 
K Information to share 
about fronto temporal 
dementia 
15 11 Nine posters are PALS, one is 
a PLM staff member, and one 
is a PALS caregiver. 
P Front teeth erosion 7 6 Five posters are PALS, one is  
family of a PALS. 
B Itching 1, 2, 3. 6 5 Four posters are PALS, one is 
a PLM staff member. 
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Table 5: PALS discussion threads referred to in findings about authoritative knowledge. 
Thread Subject line Total # 
posts 
# 
Posters 
Notes 
N IVIGlobulin Therapy 19 9 The first nine posts by six 
posters occur in two days; 
three people posted twice. The 
next six posts were made by 
one individual—a PLM staff 
member, not a PALS — eight 
days later. The final four posts 
were made in two days three 
months later, by two new 
posters and two individuals 
who posted in the original set 
G Proactive MDs 10 6 Whole thread occurs within 
24 hours. 
M What have you done to 
your gut? 
22 19 All posters are PALS. 
H ALS & Neurotoxins 10 10 Eight posters are PALS, one is 
a caregiver, one is coded as 
"Other." 
J What trigger your ALS? 14 9 All posters are PALS. 
E Glutathione 28 13 26 posts are from PALS, two 
are from a PLM staff member, 
and 4 posts are blank. 
 
 
